Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886744-25-000052
Filing Date
2025-08-06
Accepted
2025-08-06 16:11:47
Documents
65
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q gern-20250630.htm   iXBRL 10-Q 1600883
2 EX-31.1 gern-20250630xexx3111.htm EX-31.1 10226
3 EX-31.2 gern-20250630xexx3121.htm EX-31.2 10305
4 EX-32.1 gern-20250630xexx3211.htm EX-32.1 5069
5 EX-32.2 gern-20250630xexx3221.htm EX-32.2 5109
  Complete submission text file 0000886744-25-000052.txt   7037846

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gern-20250630.xsd EX-101.SCH 44618
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gern-20250630_cal.xml EX-101.CAL 66926
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gern-20250630_def.xml EX-101.DEF 220347
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gern-20250630_lab.xml EX-101.LAB 585822
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gern-20250630_pre.xml EX-101.PRE 393282
68 EXTRACTED XBRL INSTANCE DOCUMENT gern-20250630_htm.xml XML 1002070
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20859 | Film No.: 251189685
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)